Individual instructions are included for each opportunity listed.
Archived funding opportunities from the past year can be found here.
| Funding Source | Grant Name | Description | Deadline |
|---|---|---|---|
| Cures Within Reach |
Repurposing Research to Address Diversity, Equity and Inclusion in the Greater Chicago Area
|
Cures Within Reach is seeking clinical repurposing trials from any research institution in the greater Chicago area to address Diversity, Equity and Inclusion (DEI), including repurposing clinical trials that EITHER are led by an underrepresented researcher OR address health disparities among underserved patients OR both. While the funded institutions must be in Chicagoland, patients and collaborators can be both within and outside the Chicago area. Clinical trials utilizing telehealth or other remote strategies are encouraged to apply. More information |
06/26/2023
LOIs Due
|
| AbbVie Ventures |
2023 AbbVie Innovation Midwest Award
|
AbbVie Ventures is excited to launch the 2023 AbbVie Innovation Midwest (AIM) awards, our signature event to catalyze the formation of new biotech companies and support a thriving biopharma ecosystem in our backyard. AIM awards will be granted to up to two early-stage biotech companies, offering seed funding under standard industry terms.
AbbVie Ventures is focused on novel science and technology with the potential to generate transformational therapies in areas that align with our strategic areas of interest.
Application core requirements: The AIM award is limited to biotechs (and biotechs-to-be) working on next-generation biologics, small molecules, genetic medicine technologies (including RNA and DNA-based therapies, in situ cellular programming, and gene therapy delivery), and platform technologies for target identification and validation in the following areas: Immunology, Oncology, Neuroscience, Eye Care and. Genetic Medicine Technologies (RNA and DNA). Exclusions: Diagnostics, Devices, Research Tools, Nutrition, and Healthcare Services/IT. More information
|
07/07/2023
Application Due
|
|
Institute for Translational Medicine
|
TL1 Postdoctoral Program in Clinical Research, Biomedical Informatics, and Health Equity
|
The TL1 Postdoctoral Program in Clinical Research, Biomedical Informatics, and Health Equity is a National Research Service Award (NRSA) funded training program comprising participating degree programs at the University of Chicago, Rush University, and Loyola University Chicago. The program will prepare postdoctoral trainees with clinical (MD, DNP, PharmD, DMD/DDS, etc.) or research degrees (PhD) with the skills to conduct independent and collaborative research that will transform the science and practice of medicine, improve clinical practice and health outcomes, and advance health toward health equity. More information
|
08/01/2023
Application Due
|